Schätzlein, Andreas G.
Nanomerics Ltd,
United Kingdom
2025 Rank: 111812
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1021 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 111812 | 119584 |
| Total Cites | 6913 | 7835 |
| H-index | 41 | 43 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 277 | 284 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 569 | 599 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 2270 | 2437 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5795 | 6133 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.28 |
| Self-Citation Percentage |
11.77%
|
|
Schätzlein, Andreas G.
UCL School of Pharmacy,
United Kingdom
2024 Rank: 109785
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1013 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 109785 | 114819 |
| Total Cites | 6548 | 7400 |
| H-index | 39 | 43 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 269 | 276 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 556 | 586 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 2201 | 2361 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5464 | 5787 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.28 |
| Self-Citation Percentage |
11.51%
|
|
Schätzlein, Andreas G.
University College London,
United Kingdom
2021 Rank: 97421
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 939 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97421 | 101814 |
| Total Cites | 5553 | 6311 |
| H-index | 37 | 41 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 250 | 257 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 509 | 539 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 1953 | 2098 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4586 | 4873 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.30 |
| Self-Citation Percentage |
12.01%
|
|
Schätzlein, Andreas G.
UCL,
United Kingdom
2020 Rank: 92372
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 844 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92372 | 96646 |
| Total Cites | 5189 | 5884 |
| H-index | 35 | 39 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 242 | 249 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 501 | 518 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 1854 | 1982 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4254 | 4510 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.30 |
| Self-Citation Percentage |
11.81%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.